Ovid Therapeutics (1OT.F) Q4 2023 Earnings

8MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.2
-0.15
-0.1
-0.05

Details

Expected EPS
-0.046117221800000004
Actual EPS
-0.20105800000000001
Surprise EPS
-0.15
Surprise Percent
+335.97%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.20105800000000001 per share for Q4 2023.

0 Comments

Share your thoughts